ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Clinical Outcomes In A Large Transplant Cohort Hospitalized With COVID-19: Mycophenolate Mofetil (MMF) Utilization And Mortality Trends

    R. L. Gottlieb1, M. Askar2, L. Chen3, A. Chandak4, E. Mozaffari3, M. Thrun3, R. Haubrich3

    1Baylor Scott & White Research Institute, Dallas, TX, 2Baylor University Medical Center, Dallas, TX, 3Gilead Sciences, Foster City, CA, 4Certara, New York, NY

    *Purpose: To characterize demographics, treatment patterns, and outcomes among 3,998 transplant patients hospitalized for COVID-19 over 16 months of the pandemic (May ’20-Aug ’21).*Methods: Adult…
  • 2022 American Transplant Congress

    Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients

    M. Ji1, S. Chang1, M. Wang1, K. Lentine2, M. Merzkani1, H. Murad1, M. M. Ibrahim1, M. Zayed1, J. Wellen1, S. Sutcliffe1, T. Alhamad1

    1Washington University in St. Louis, Saint Louis, MO, 2Saint Louis University, Saint Louis, MO

    *Purpose: Simultaneous pancreas-kidney transplantation (SPK) is the only persistently successful treatment option for patients with diabetes mellitus and end-stage renal disease. However, SPK carries a…
  • 2022 American Transplant Congress

    Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?

    A. Kwong1, W. Kim1, D. Schladt2, A. Wey2, J. Snyder2, A. Israni2, J. Lake3

    1Stanford University, Stanford, CA, 2Hennepin Healthcare Research Institute, Minneapolis, MN, 3University of Minnesota, Minneapolis, MN

    *Purpose: In the United States, priority on the liver transplant waitlist is determined by the model for end-stage liver disease (MELD)-Na, a score composed of…
  • 2022 American Transplant Congress

    Immune Checkpoints, Immune Cells, and MHC Expression in the Tumor Microenvironment of Resected Hepatocellular Carcinomas

    A. Baquerizo1, V. Vavinskaya2, S. Bagsic1, A. Rojas3, A. Mhoyan4, C. Frenette1, L. Sher5, M. Romero3, J. Fisher1, C. Marsch1, R. Schaffer1

    1Scripps, La Jolla, CA, 2UCSD, San Diego, CA, 3University, Seville, Spain, 4Kaiser, San Diego, CA, 5USC, Los Angeles, CA

    *Purpose: Advances in tumor biology has shown the important role of the tumor microenvironment (TME) in tumor growth and metastasis. A better understanding of the…
  • 2022 American Transplant Congress

    Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation

    K. Genena, D. Milliner, J. Lieske

    Nephrology and Hypertension, Mayo Clinic, Rochester, MN

    *Purpose: To demonstrate the role of simultaneous liver kidney transplant in PH2*Methods: A 30-year-old white man presented to our center for evaluation of chronic kidney…
  • 2022 American Transplant Congress

    Heart-Kidney Transplantation Appears to Be Acceptable for Patients Greater Than 65 Years of Age

    T. Singer-Englar, M. Kittleson, J. Patel, N. Patel, S. Kim, D. Chang, E. Kransdorf, L. Czer, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Heart-kidney transplantation (HKTx) has been found to improve survival in patients with advanced kidney disease who undergo heart transplantation. It is not known whether…
  • 2022 American Transplant Congress

    Factors Contributing To SARS-CoV-2 Vaccine Hesitancy In Kidney Transplant Candidates

    P. LaBella1, E. Silverman2, S. Mehta3, N. M. Ali4

    1Transplant Infectious Disease, New York University Langone Health, New York, NY, 2Transplant Infectious Disease, New York University Grossman School of Medicine, New York, NY, 3New York University Langone Transplant Institute, New York, NY, 4Transplant Institute, NYU Langone Health, New York, NY

    *Purpose: SARS-CoV-2 infection in kidney transplant recipients is associated with an increased risk of severe disease and mortality relative to other patient populations, with mortality…
  • 2022 American Transplant Congress

    ROImax Score: A Novel Predictor for Adherent Perinephric Fat in Healthy Donor for Transplantation Underwent Laparoscopic Donor Nephrectomy

    T. Noda, Y. Miyauchi, K. Nishimura, T. Fukumoto, N. Miura, T. Kikugawa, T. Saika

    Ehime University Graduate School of Medicine, Toon City, Japan

    *Purpose: MAP (Mayo adhesive probability) score have been known as a predictor of adherent perinephric fat (APF) in partial nephrectomy. This study is aimed to…
  • 2022 American Transplant Congress

    Racial/Ethnic Disparities in Rates of Living Donor Liver Transplant Are Partly Explained by Socioeconomic Deprivation in Adults

    S. Frey, T. Ishaque, C. Qin, A. Cameron, A. Massie, D. Segev, E. King

    Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Living donor liver transplant (LDLT) is an important strategy for addressing the deceased donor liver shortage and is associated with improved survival but represents…
  • 2022 American Transplant Congress

    Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: An Analysis of the European Liver Transplant Registry

    M. P. Claasen1, T. Ivanics2, J. N. IJzermans1, G. Sapisochin2, W. Polak1

    1HPB and Transplant Surgery, Erasmus MC, Rotterdam, Netherlands, 2Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada

    *Purpose: Little is known about combined hepatocellular-cholangiocarcinoma (cHCC-CCA) demographics and their long-term outcomes after liver transplantation (LT). By analysing data from the European Liver Transplant…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences